Authors: SANOSKI CA SCHOEN MD GONZALEZ RC AVITALL B BAUMAN JL

Citation: Ca. Sanoski et al., RATIONALE, DEVELOPMENT, AND CLINICAL OUTCOMES OF A MULTIDISCIPLINARY AMIODARONE CLINIC, Pharmacotherapy, 18(6), 1998, pp. 146-151

Authors: KONG SXD CRAWFORD SY GANDHI SK SEEGER JD SCHUMOCK GT LAM NP STUBBINGS J SCHOEN MD

Citation: Sxd. Kong et al., EFFICACY OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA - A METAANALYSIS OF CLINICAL-TRIALS, Clinical therapeutics, 19(4), 1997, pp. 778-797

Authors: SCHOEN MD DISCHLER JE CONNER SE ZERVOPOULOS PC KLINE CA BAUMAN JL

Citation: Md. Schoen et al., ECONOMIC OUTCOMES AND MEDICATION COMPLIANCE IN A PRESCRIPTION PROCUREMENT CLINIC FOR INDIGENT PATIENTS WITH CARDIOVASCULAR-DISEASE, Circulation, 96(8), 1997, pp. 3446-3446

Authors: JANNSEN RK MURPHY CM KENDZIERSKI DL BROWN DH CARTER BL FURMAGA EM SCHOEN MD WOKER DR

Citation: Rk. Jannsen et al., AMBULATORY CARE CERTIFICATE PROGRAM FOR PHARMACISTS, American journal of health-system pharmacy, 53(9), 1996, pp. 1018-1023

Authors: PHILLIPS BG BAUMAN JL SCHOEN MD HOON TJ SCHRADER BJ RICH S

Citation: Bg. Phillips et al., SERUM NIFEDIPINE CONCENTRATIONS AND RESPONSE OF PATIENTS WITH PULMONARY-HYPERTENSION, The American journal of cardiology, 77(11), 1996, pp. 996

Authors: PISCITELLI DA FISCHER JH SCHOEN MD HOON TJ BAUMAN JL

Citation: Da. Piscitelli et al., BIOAVAILABILITY OF TOTAL AND UNBOUND DISOPYRAMIDE - IMPLICATIONS FOR CLINICAL USE OF THE IMMEDIATE AND CONTROLLED-RELEASE DOSAGE FORMS, Journal of clinical pharmacology, 34(8), 1994, pp. 823-828